SLC27A3 and glioblastoma: Inhibition of the HGF/c-Met signaling pathway with a small molecule tyrosine kinase inhibitor SU11274 completely blocked HGF-mediated ACSVL3 up-regulation, confirming that multiple oncogenic RTK signaling pathways induce ACSVL3 expression in GBM neurosphere cells (Figure 5B).